<SEC-DOCUMENT>0001434265-25-000102.txt : 20251120
<SEC-HEADER>0001434265-25-000102.hdr.sgml : 20251120
<ACCEPTANCE-DATETIME>20251120152239
ACCESSION NUMBER:		0001434265-25-000102
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20251120
FILED AS OF DATE:		20251120
DATE AS OF CHANGE:		20251120

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENMAB A/S
		CENTRAL INDEX KEY:			0001434265
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38976
		FILM NUMBER:		251502689

	BUSINESS ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000

	MAIL ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>gmab_20251120x6k.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if3fed240cfbb44878035eb66b99b509b_1"></div><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><br>FORM&#160;6-K<br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE&#160;13a-16 OR&#160;15d-16</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE&#160;MONTH OF NOVEMBER 2025<br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMMISSION FILE NUMBER 001-38976  </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Genmab A&#47;S<br></font><font style="background-color:#ffffff;color:#333333;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Carl Jacobsens Vej 30</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2500 Valby</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Denmark</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+45 70 20 27 28<br></font><font style="background-color:#ffffff;color:#333333;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Address of principal executive offices)<br></font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.936%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:2pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or&#160;Form&#160;40-F.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form&#160;20-F&#160;</font><font style="font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      Form&#160;40-F&#160;</font><font style="font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This report on Form&#160;6-K&#160;shall be deemed to be&#160;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">incorporated by reference</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;in Genmab A&#47;S&#8217;s registration statements on&#160;Form&#160;S-8&#160;(File&#160;No. 333-232693, </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">333-253519, 333-262970, 333-277273 and 333-284876</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">)&#160;and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:3pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT&#160;INDEX</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.305%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description of Exhibit</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%">Company Announcement Dated November 20, 2025&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a href="gmab_20251120xex99d1.htm" style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of Restricted Stock Units and Warrants to Employees in Genmab</a></font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:63.36pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SIGNATURE</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.825%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.272%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GENMAB A&#47;S</font></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anthony Pagano</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58; Anthony Pagano</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58; Executive Vice President &#38; Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATE&#58; NOVEMBER 20, 2025</font></div><div><font><br></font></div><div style="height:63.36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>gmab_20251120xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id695dd2742264c338d86c241926d4a6b_1"></div><div style="min-height:118.8pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Exhibit 99.1</font></div><div style="padding-left:288pt;text-indent:36pt"><font><br></font></div><div style="padding-left:360pt;text-indent:36pt"><img alt="genmab_logo.jpg" src="genmab_logo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:112%">Grant of Restricted Stock Units and Warrants to Employees in Genmab</font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Company Announcement</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">COPENHAGEN, Denmark&#59; November 20, 2025 &#8211; Genmab A&#47;S (Nasdaq&#58; GMAB) announced today that the Board of Directors decided to grant 6,933 restricted stock units and 7,377 warrants to employees of the Company and the Company's subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Each restricted stock unit is awarded cost-free and provides the owner with a conditional right to receive one share in Genmab A&#47;S of nominally DKK 1. The fair value of each restricted stock unit is equal to the closing market price on the date of grant of one Genmab A&#47;S share, DKK 1,957.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The restricted stock units will vest on the first banking day of the month following a period of three years from the date of grant. Furthermore, the restricted stock units are subject to vesting conditions set out in the restricted stock unit program adopted by the Board of Directors.</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Information con</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">cerning Genmab&#8217;s restricted stock unit program can be found on </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">www.genmab.com under Investors &#62; Governance &#62; Compensation &#62; Restricted Stock Units. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The exercise price for each warrant is DKK 1,957. Each warrant is awarded cost-free and entitles the owner to subscribe one share of nominally DKK 1 subject to payment of the exercise price. By application of the Black-Scholes formula, the fair value of each warrant can be calculated as DKK 612.85.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The warrants vest three years after the grant date, and all warrants expire at the seventh anniversary of the grant date. The new warrants have been granted on the terms and conditions set out in the warrant program adopted by the Board of Directors on February 23, 2021. Information concerning Genmab&#8217;s warrant schemes can be found on www.genmab.com under Investors &#62; Governance &#62; Compensation &#62; Warrants.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">About Genmab </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Genmab is an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody therapeutics. For more than 25 years, its passionate, innovative and collaborative team has invented next-generation antibody technology platforms and leveraged translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab&#8217;s vision is to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO) antibody medicines</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8239;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Established in 1999, Genmab is headquartered in Copenhagen, Denmark, with international presence across North America, Europe and Asia Pacific. For more information, please visit </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Genmab.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8239;and follow us on </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">LinkedIn</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">X</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.<br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contact&#58;&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marisol Peron, Senior Vice President, Global Communications &#38; Corporate Affairs</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T&#58; +1 609 524 0065&#59; E&#58; </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">mmp&#64;genmab.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andrew Carlsen, Vice President, Head of Investor Relations</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">T&#58; +45 3377 9558&#59; E&#58; </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">acn&#64;genmab.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">The Company Announcement contains forward looking statements. The words &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;intend&#8221; and &#8220;plan&#8221; and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product </font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Genmab A&#47;S<br>Carl Jacobsens Vej 30<br>2500 Valby, Denmark</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tel&#58; +45 7020 2728<br>www.genmab.com<br></font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company Announcement no. 52</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 1&#47;2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR no. 2102 3884</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LEI Code 529900MTJPDPE4MHJ122</font></div></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:118.8pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="padding-left:288pt;text-indent:36pt"><font><br></font></div><div style="padding-left:360pt;text-indent:36pt"><img alt="genmab_logo.jpg" src="genmab_logo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:153px"></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:112%">Grant of Restricted Stock Units and Warrants to Employees in Genmab</font></div><div style="text-align:justify"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab&#8217;s most recent financial reports, which are available on </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.genmab.com </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">and the risk factors included in Genmab&#8217;s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at </font><font style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">. Genmab does not undertake any obligation to update or revise forward looking statements in the Company Announcement nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Genmab A&#47;S and&#47;or its subsidiaries own the following trademarks&#58; Genmab</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#59; the Y-shaped Genmab logo</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#59; Genmab in combination with the Y-shaped Genmab logo</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#59; HuMax</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#59; DuoBody</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#59; HexaBody</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">&#59; DuoHexaBody</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">, HexElect</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">&#174; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">and KYSO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="height:72.72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Genmab A&#47;S<br>Carl Jacobsens Vej 30<br>2500 Valby, Denmark</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tel&#58; +45 7020 2728<br>www.genmab.com<br></font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company Announcement no. 52</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Page 2&#47;2</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR no. 2102 3884</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">LEI Code 529900MTJPDPE4MHJ122</font></div></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>genmab_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 genmab_logo.jpg
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M:&]P(#,N,  X0DE-! 0       \< 5H  QLE1QP"   "  ( .$))300E
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M5SB")%4V0U-C<X,9P=&2HC1D)66E*;&RE,34$0$  0(# 0D*"@D# P0" P
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M.GC3_M(%5)6?[34,"[8N6_2B86S(ZKE,]&-B[37R3N\\;8YX9P?)(
M                                 ^==+Q:;'1R7"]72DM%!%_"5M;,R
M")ONOD5J?M@:(OW5+L]8WR10WNIO\T6J.CM=*^1-4[FRS>%&[W4<J!S@P)_6
MC@"/<D>+Y ^-%]!SFTK55/.B5"Z?L@P?6M?6)M=6O;'7T%]LRJNBS34T4L2(
MO?K#,]__ +@,&^\3W$PC.8W/Q3)J*\O8WGDI8G\E0QOUSX)$;*U./:K0X9H
M
M
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MRKH<.W+J6R353VP6G+7<K/3=P9'6Z:)Q71$D1/W?>XY=9A.\.
M
M
M  &)9YE]NP##<ES.[<:'&[?-6R1:Z+*Z-OVN)JZ+HZ1ZM8GG4^EFW-RN*8WY
M86HYZC)9:Y?KV44S/+P1SSN.=;,\NOF>Y3>\PR.J6LO-_JGU59+QY6\W!L<:
M*J\K(VHC&)W-1$+G:MTVZ8IIV0\PY_.W<[?KOW9QJJG&?)'%&R.)C!]&(
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M>RAK9GKJ^:F>BK2RN[U7E:YBJO:K-5XJ<NLI)!P
M
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MUDI-R;Q:U>B07:Q3*L:KIK+3SPO8J)WZ-5_[(<2LR.74
M
M                                                       "$_7S
M:9[EL73UD2*L=@R:WU]3IW,?#4T::_[52TE-(JPO8<,3Y5![1[,W-+BJ/5N4
MS/<JI^LI:+.T.         .A/IVS:?<+9? ,FK9UJ;E-;DHKK.Y=7OJJ![J2
M61^OU4CHN=?=*=G;7LKU5,;,?#NO3'5C4)SVFV;U4XU='">6GS9GGPQYVZC%
M3P                               4H[GY5)FN?Y9DKI?%AN-PE]0=KK
MI2Q+X5,GO1,:<.S PY        ):]'%L?5;FW6XJS6&U6&=5D5-=))IX8V(G
M'@JMY^/F#B5FIRZ@
M
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MG4-EID<FCDH:7F9"NB\4YWND=YV\JG+K*60<
M
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ML@
M
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MXB:(FB(B'+JS(
M
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M37R(SSZG+C%,>WV^@M-%3VZUT4%NM](Q(Z6BIHVQ11M3N:QJ(B)[@</<
M
M
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M(![@
M
M                                   T9U'8K)E>T>30T\?B5ME:R\4C
M435=:->:71$[UA61$\X<PJ(.'8         6R=+5REN&S..QS*KG6NHKJ-KU
M[5:VH?(WO7L21&I[ARZRD,'     /%/,RG@FJ)-?#@C=(_3BNC4U73]@"B:X
M5L]SKZVXU3N>IN%1)4U#_+)*Y7N7]E3AW>F         G3T6XK*^OR_-9HE;
M!!!'9J"54X/?*YM14(GG:C(O_:.765@(<
M
M
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ME(K99*&+GN-6U-/'JY5YYI.*(NBN71NO8U$3N.71GH
M
M
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MH(Y,UKXW,@IT5LC+=3O3BQJIJBRO^K<B\$]%/JE=RZS*4X<
M
M
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M@<N)EO8.
M
M                                                     P7*]LL
MS?F=E.*4%UG<G*M<Z/PJK1.Q$J859*B>9' :)NO1WMA6R.EMUPOEE55X015$
M4T2)Y$2:%[__ 'PYQ8Y'T58FCVK-F=V?&GPF,A@8Y?<<J.1/V 8L^L'2?M%9
M7LEK*&XY)(Q45ORG5KR:I]A3-@:J>9R*#%(.TV:T6&ABMEDME+:+?!_!45'"
MR")JKVJC&(B:KWJ'#Z0'\541%55T1.U0*_=]>J"LGJ*W$-LZU:6C@<Z&Z9="
MOVV9R<',HW?4,3BBR)Q=]1HGI..8A!V:::HEDGJ)7SSS.5\TTCE<][G+JKG.
M75555[U.'9X@ &_-H=_LKVPJJ>@GFEOV'.<B55@F?JL#57B^C>[7PW)Q7E^
M[O1%7F0XF%I^,9/9,QL=OR/'JUE?:KE'ST\[>"HJ+HYCVKQ:YJHJ.1>**<NK
M[X'\5$<BM<B.:Y-%1>**B@:3RKIXVDRV26HJ\6BM==+JKJZTO=1.U7M58X_M
M+E7RN8JASBU'6=%V#2.5:#*[[2L5=4;/ZM.J)IQ35L47>#%[%!T8[?0N8ZX9
M)?Z[E3TF1/IH&N77O^T2+IIY%]\&+;^,;![2XF]D]NPZDJZR/14K;DKJY_,G
M8YJ5"O8Q?.UJ Q;A1$:B-:B-:U-$1."(B!P_H
M
M
M                              0]ZK]V9L8LD. 6*I6&]9- LEZJ(UT=
M!;G*K%8BHO!TZHK?W".^N10YA6N<.P    )-=,^[4N!9;%CEUJ=,4RJ9D%0C
MW:,I:QVC8:A->"(JZ,?YM%7X(<3"U Y=0
M
M
M                                >.::*GAEJ)Y&Q0P,=)-*Y=&M:U-7
M*J^1$0"D_<;,*C/,WR/*JASN2ZUCW443M=8Z5GH4\?\ LQM:B^<X=F$AR
M  !<=L9FK\\VQQN]54OC7.GB6WWAZ\7+4TB^&Y[O/(U&R?[1RZ2VX
M
M
M                                                    -3;[7N3'
M]HL]N,3UCD?;'44<B:ZM6O>RD145.**GC<%[@0IN.'<      !8'T47M\ELS
MK&WO^UTE527*EC^RJ&/AF7]B",Y=93G#@
M
M
M                               (V=6,SXMF[I&U$5*FXT$<BKVHB3(_
MA[[$#F%5!P[       )E]%LKTS?+84=]JDL:/>W1.+F5,2-77MX(Y0XE8^<N
MH
M
M                                                           1
M_P"J"WOK]ELJ=&Q'R6^2AJVIIQT95Q->J>31CE7W YA4J<.P      ";?11;
MW29%G5TY?1H[=24JNX\%J9GO1/)Q\!3EUE8>'
M
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MZM=>,SJ>HTV+U-%-%45881..,1TMLS.]$\"QTA6T0
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M90W6CJ':\.&D<KE[SY56+E.VF8YI2%G5LG?]W>MU<E5,^"6;GR2
M
M                                        0-Z^]O8K_MC;,]IH=;G@
ME>QE7*G:MON+FP/1=.WEG\)4\B*[RDMI%[HW)HWJO##77:1ID7\E3F8CSK4[
MOQ:MSZ71[ZG0LK1P!M38Z_KC&\6V=[\18XJ3([>RK>W37U>>=L,^FOEC>XQ\
MU1T[54<4ICJ_F?N^HV+G!73CR3.$]Z9=%)3'IX
M                *K.J/;J7#MPJF_4D"ML.:.?7TTC4]%E9JGK<2^=7KXB>
M9^B=BG#M"- <@    R3$,7N6:9-9<7M$:OKKU5,IXW:*Y(VKQDE>B?4QL17N
M\R*!=;CMBH,8L-GQVUL6.WV6DAHZ1%^$K(6(U'.7O<[355[U.71]D
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MRJJ]B(Y'K]:1&8TZ[9W<,8X8;(T?KGI^I3%,5="N?5KW.Y.R>[CQ)-&"M@
M
M                                          # -UL:;F.V>>XQX22R
M7JPU]-2-7NJ'0/6!R>=LB-5/</MEZ^A<IJX)A&ZSE/O>2O6?A451'+AN=_!S
M@EU>6P#S4U1+25$%5 [DGII&RPO[='L5'-7]E#B8Q=J:IIF)C;#ILH*N.X4-
M%7P_P5;!'41:*B^C(U')Q3@O!2C3&$X/6-NN*Z8JC9,8]U[9P[@
M                           # -S-O;1N;B=?C%V^U.ETFMEP:FKZ6J8B
M^'*WR]JHY.]JJGG I^S/#+_@605N-Y'1.I*^C<O))H[PJB+54;- ]R)SL=IP
M7WET5%0X=F*AR  /)%%)-)'##&Z6:5R,BB8BN<YSET1K43BJJO8@%G_39LC)
MM[:WY5DU,C<POD*-CI'HG-;J1WI>%_WDG!7^31&_7:\NLRE.'
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M5JKHNCDU:[1>5RE<OY>NQ5T:H;NTC6LKJEKVN7JQX8]:F>"J/TB=Z6RSX)4
M
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MEME)!>:R3\ILM8WT+M.Q&0TRKV^JPZNY5TX<[E5WDY454.7&*1 <
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M&/&LO5*QG;NH41E*IIJ]:K>BC?Z4;)CBG;.'*O[*@](@
M
M                           <[6_%*M)O9NU"JH[7+[S*G*FB(DU;+(B>
M\CM"YY2<;-')'@>8NL5'1U/,Q_ZM??JF6IS(0P!T:;-5$E7M!M552Z>+4X?8
MI9.7@G,^WP.71/=4I>9C"[7\:?"]0Z%5-6GY>9W[5'T8;)/@E0
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MHQL>B>J?5VG1\KT:MV[7NUSX*8XJ>_.,I'&$M(
M
M                     '/-U#?3GNQ\Z+C\>XN63]S1R0\R]9OS3,?:5>%I
MLR4& =%NR/T+[0_,JP?@Z I>:]]7\:?"]/\ 5_\ +<M]E;^C#:!\$N
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MZM:]R*Y$7MX)I]XS-R+?L\?-156B9.K-QFYMQ[6/6\<QLF>"9W6RCX)4
M
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MX[N!#3V"]SJV*COD2\E#4O[$;*CU58'KPT756JOUO!%Y<3"8H<
M    (I=86[4FU^TU;2VJK2FRC.'OL]E5JZ210.9K65#/^[B7D14XM>]BDAIN
M7]M=W=D;OD4WKQK4Z=D)IHG"Y<\VGAB/6JYHW.*9A1>6MY[ /8I:6IKJJFHJ
M.!]565DK(*6FB:KGR22.1K&-:G%5<JHB(<3.$8R[4455U133&,SN1'&Z"M@-
MHZ'9G;:S8LR.-U\J&I7997LXK/<)FHLB<VJZMB1$C9]BW7355*?G,Q-^Y-6]
MO<CTKU;T6G2<E39]>=VN>&J=O-&R.*&ZS%3X
M
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M3^%C8Y7QKQ['(BF#<LUV_2B86O)ZEELY3TK%RFN/V9B<.6-L<[+3YLT
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M8Q7*[D=R.1%<B+JB\!F,I<L8=/?=M&ZPY35HK^[S,]"8QQC#;LGDVMP&,FP
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M?77"=]1)R]S6J]5Y6IW(G!.XF:+=-$84QA#66:SE[-5^TO5S75PS.+X!W8P
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M5&D!G-+JM^=;W8X-_P#6V]U;Z_VLY,6<YA1<G95ZE7+\&>]/#&Y"?9$-D
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M.O>=S^-%J?96^"F?.GEJV\T81PXH>N<YSE<Y5<YRZN<O%55>U54DE(VOX
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MD<U*IFLM5EZ^C5S3PO0^@Z[8U?+Q>M;DQN54[],\')P3O\N,1MTQDV
M                  $>>J6N6CV6R6)K^1UQJ*"F1>.JIZW%*Y$5.S5(UUUX
M::H',*FSAV       35Z*JU\>59K;D5?#JK5!4O3NYJ>?D;^U,H<2L5.74
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M<=RN5D-_8YSY5H+@C>5JZKKRQ3M;Z/<UZ*W@CF(6/2LU%5/LYVQLXX:3[0M
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MP4I]=$T3-,[8>D\MF+>8M4W;<XTU1$Q/%+ZYU?<
M  1PZK:5U1LS>Y6ZZ4-;;YWZ)JFBU#(N/DXR(',*I#AV       3.Z+()'9I
ME]4B?:H;*R)Z_925,;F_M,4Y=96.!P          %-GM [IZYO-8[<UZ+':,
M6I&/8BHNDLU552N5=.*:L5G!?=[RRZ/3A9F>&?(T9VE7NGJ-%/P;<=V9JGP8
M(*DLUX 2:Z/+4V[=1.WK)$UAH9*^NDX\=:>@J'QJG_B(TP=2JZ.7JYO"MG4>
MS[76+..R.E/<IG#OX+XRI/10                    "L?KVWKEITH]EL?J
MU8Z>.*XYS+&[1>1VCZ2B71>_1)GIY/#\JH3ND97'^+/-Y6INT;7YIPR%J=N%
M5?U:?K3\GC5=$\U$ 2?Z5MBUWIS[_P"L0O\ R'Q1(ZW)Y&ZM]85SE\"B:Y.*
M+,K55RIV,:[14=RF!J&;]A1N>E.SRK;U/ZO?B^;\^/X5&[5Q\%/RM_BB=_!>
MK145';:.EM]OI8J&@H8F045% QL<444;4:QC&-1$:UJ(B(B)P*I,S,XR]#6[
M=-NF*:8B(B,(B-D0]DX=P   ]*Y6VWWBWUMJNM%#<;9<87T]?05#$DBFBD16
MO8]CD5%147144YIJFF<8VOG=M47:)HKB)IF,)B=DPH<ZG=E%V4W&GM=N;(_$
M<@C6XXG42*KE;"KM):5[E[70/X=JJK%8Y>+BVY#->WMXSMC:\Z];= _",Y-%
M/NZO.HY-^GEIGO83OHY&:JX!;?T ;HRWS%+]M==*CQ*S$'?*./<ZZN6W54BI
M-&GFAG77_P 1$[BNZQE^C5%R-_;RMT]FVKS>L5Y.N=VWYU/Q9G=CFJ^DL.(9
MLT   (K=:E-X_3CG4O/R>I3VB;ETUYM;G2Q:=O#^$U]XD-+G#,4\_@E3^OM'
M2T>]/!-$_OTQXU%9:WGD  9#B^*9'FM[HL<Q2SU-]O=P=RTMOI6<SE\KG*NC
M6-;VN<Y4:U.*JB'2Y<IMT]*J<(9.3R=[-W8M6:9JKG9$?IN1QSN0M4V2Z%,9
MQME'D&[<L667U$;+'BT*K\ETSN"HDSN#JER=Z+I'VIRO3B5_-:M55N6]R.'?
M_4W%H'9Y9R^%W.^?7\"/0CE^%]'BE/ZBH:*VTE/06ZC@M]#2,2*DHJ:-L4,3
M&]C6,8B-:B>1$(B9F9QELBW;IMTQ33$1$;(C<B'M'#N  /0NEKMU[MM?9[O1
MQ7"UW2"2EN%#.WFCFAE:K7L<B]J*BZ'--4TSC&V'SO6:+U$T5QC35&$Q._$N
M?KJ"VM_P?W3R+#Z=9'V9KF5^-SR*JN?052*^)'.73F6->:)SN]S54N&3S'M[
M45;^_P KS7UETC\*SU=B/1VT_%G9W-G+#2QE($ N$]GODC[CM;E&-S/5[\:O
M[I:=%[&4]? Q[6I_XL4B^^5O6*,+L5<,>!N_LTS4W,C<M3ZE?>JB/'$I\D0V
M.    #GDZA&-9OENRC&HQ%RFYN5$31-75#U5??5=5+ED_<T<D/,O6:,-4S'V
ME7A:=,E!@ "<W3YT89'N/'1Y7N&ZJQ'"I>6:BH$:C+E<HUXHYC7HO@1.[4>]
MJN<GP6Z*CR*SFITVO-HW:N]#8/5KJ)>S\1>S6-NUO1Z]?_;''.[.]&^MJPS!
M,0V\LL./878*3'[5#Q6"F9Z4CM-/$FE<JOE>O>Y[E7SE=NW:[L]*J<9;HR&G
M9?(VXM6*(IIXO#,[9GCEEI\V:  -9[M[6X[O!A-TP[(H6HE2U9;3<T:BRT-8
MQ%\*HB7MU:JZ.37TFJK5X*??+YBJQ7%5/_5$ZUH]G5,M58NQMV3OTU;TQ^F[
M&XYX+S::VPWBZV*Y1^#<;+63T%?$G'EGII'12-[NQS50N5-451$QLEYDOV:K
M-RJW7Z5,S$\L3A+YIV?(  ;*VMVGS3>#)(L:PRVK53-Y7W.YRZLHZ&%RZ>+4
MRZ+RIP71$17.[&HJGPS&8HL4]*J?UI72-&S.J7O96*<9WY]6F.&J?TF=Y=/L
M9TT8'LE0Q5-' W(,TFBY;EE]7&WQ=7)H^.D9Z201KY$57+]4YW#2L9O/5YB=
MW<IX&^>KW53*Z13C3'2N[]<[>2GX,=_AF4C#"6@  ?E[&R-<Q[4>QZ*U[')J
MBHO!45%#B8Q4%]4>U]+M1O#?[':J?U7';NR.]8W3HFC8Z6K5W-"U/K8IF21M
MX_!:FO$M^0OS>M1,[8W)><.M^D4Z9J-=NB,**O.IXHJWN:<8CBA'@S%9 +<O
M9WY&^MV_SK%Y).?Y OD-="U5U5D=Q@Y$;IKP3FI7*GG52NZS1A<IJX8\'_5N
MKLQS4UY2]9GU:XGYT?\ XRL+(9LP   /@93C%DS3';QBN1T3;C9+[3/I;A2/
MX<S']BM7M:YJHCFN3BUR(J<4.]NY-NJ*J=L,;.92UF[-5F[&-%483'Z=[@ES
M\;S;3WS9S/;KAEV1U1!&[Q[!=4;HVNH9%7P9FIW.X<KVI\%Z.3BFBK<,MF*;
M]$51S\4O->NZ-=TK-U6*]V-M,_"IG9/BG@G%)O8?HCR;.XZ/)]S)*G#<5F1L
MM)9V-1MUK8UXHJM>BI3L7N5[5>O<Q$5'&#F]4IM^;;W9[WZULZN]0+^=B+V;
MQMV]Z/7J_P"V.7=XM]:9@.UN ;86Y+9@^,4=BB5J-J*N-G/53]G&>IDYI9.*
M:^DY43NT("]F*[TXUSBV_INCY33J.AE[<4\>_/+5.[/=9^?%)      4R]<V
MTEOP/<&VYE8:1M'9=PF3SUE+$U$CBNE.YOK+FHGP4F;(R33O=SK[EFTK,3<M
MS3.VGP-%=H6BT9+-TW[<84W<9F."N/2[N,3RXH.$JU\ 6I>SGR&66R[G8I)(
MO@6^MM]VI(N.G/61RP3KY$X4T?N^\0&M4;M-7+'Z=UN'LOS,S;OV9V1--4?*
MB8GZ,+*R#;5    !SS=0WTY[L?.BX_'N+ED_<T<D/,O6;\TS'VE7A:;,E!@'
MO6VV7&\W"CM5HH9[G<[A*V"AM]+&Z6::1ZZ-8QC$5SE7R(AQ55%,8SL?2U:K
MNUQ11$S5.Y$1NS,K1M@^A>AH8Z/*=ZF-N%P=RRTF!PR:T\/#5/7IHU^VN1?^
MC8O(FGI.>BJU(#-ZM,^;:[OD;=ZN=GM-$1>S^[.];C9'QYC;/%&YPS.Q8]0T
M%#:Z.FMULHX+=;Z.-(J.AIHVPPQ1MX(R.-B(UJ)W(B$+,S,XRVE;MTVZ8IHB
M(B-D1N1')#VSAW   "+_ %!=,.(;TVRKN='!!CVX<$6MLR6-G*VI<Q/1AKVL
M361BIP1^G.SAIJB*QV?D\_78G"=VG@\BH]9>J67U>B:Z8BB]&RKAXJ^&./;'
M>FD#*,9OF&Y!=L6R2WR6N^6.H=2W&AE[6/;Q145.#FN14<UR<'-5'(JHJ%IM
MW*;E,54[L2\_YO*7<I>JLW:>C73.$Q^G>G?C=?!.[' +3?9_[MRU='>]GKQ4
M\SK:Q]XP]7JFJ0/>GKE,W73X+WI*U$U7TI%[$(#6,OA,7(Y)\3;_ &;:U-5-
M>1KG9YU')ZU/=\Z.6I9@0;:X                       UIO'87Y-M;G-G
MBC\:>:U33TL2)JKYJ72IB:GG5\:(@%,!P[@      +$.BNPOI\>S3)9&:-NE
M?3VZG<J<=**-TKU3S*M2B>ZGF.764V@X          "C?K=K/6>H?*8?$1_R
M?06JGY43BSFHHIN5?XW7WRU:7&&7CG\+S[U_KZ6KW(X(IC]V)\:)1(J6 36Z
M"*/UG?:2;E>OR?C=PJ-6)P3FDIX=7\%X?;=/=T(O5YPL<\+[V<4=+5,>"W5/
M?B/&NG*PWR                   !C^69);L.QC(,KNS^2VX[;ZBX5G'159
M3QJ]6MU^J=IHB>53O;HFNJ*8VS+&SN:HREBN]7Z-%,S/-#G&S#*;KF^4W_+K
MY-X]UR*NFKJQVO!KI7*J,9KV-8FC6IW(B(76W;BW3%,;(>7,]G+F<OUW[DXU
M5S,SS^*-D<3&SNQ0"^_I4VVCVUV7Q>CFI_!O>2Q)?\@5R:/\>M8UT<;M4146
M*%(V*GUR.\I4=0O^UO3.]&Y#T;U.TJ-/TVW3,>?7Y]7+5LCFIPCEQ2.,):0
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M16T50R5J<W8NBU2\.[7SEAT6KS*HX_T\#37:A9B,Q8N<--4?-F)^LKC)IJX
MM ]F^]RMWD8KE5C5QYS6:\$5WRDBJB>?1"!UOU.?Q-M]EL_U7\OZZST@FVP
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M\B<$575C4L[-VKH4^C'?EOGJ3U8HT^Q3F;L8WJXQ^)3.R(XYCTIYN6:A%KZ
M      KJZ]]GH+MC=%N_9J5&W;&UBH,J\-$19[?,_D@F=IQ5T,KT;K]:_CP8
MA-:1F>C5[.=D[.5K#M'T.+MF,];CSJ,(KXZ9V3\F=SDGB5+EA:8 -B;39W4[
M9[CX?F],Y_)8;C%+7Q1_"EHY/M55$G[N%[VI[I\<Q:B[;FCAA)Z-J-6GYRUF
M(]6J,>.G95'/3BZ+O7Z+U#Y4]:C^3O5_6O7>9/#\'EY_$YNSEY>.I2\)QPWW
MJ#VE/0Z>/FX8X\7"]LX=P                     #^*B.16N1'-<FBHO%%
M10*8MX,'DV]W"R+'$B6.@94+561VBZ.HJA5?#HJ]O(B\BK]<U3AVAK,.0
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M:61T-1"ZV1HYCV*K7-7TNU%30L\:58GA[K0U7:#J],S3,TXQ^S#P_KU[_?\
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MJJX(E(Z/D_OF<LV9V55TQ/)CN]YT?M:UK4:U$:UJ:-:G!$1.Q$0I3U+L?T
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M,1G/))*]7O=RHFKG+Q55XJ5#/S,WZN5Z2ZH44TZ38PC#S<>?&6_C#60
M"L'VD'Z&OSB_%A.Z)Z_-XVI.U/\ M?YGU%8!/-2 %E?LY/ZZW6_F5I^,JB#U
MK91S^)M7LN]YF.2CPU+4B ;A               (:]=K&/V#K7/8USHKY;71
MN5$56NYGMU3R+HJH2>D^_P":5%[1(B=*GX]/C4F%H:# + _9W_2=F_S77^FT
MY#ZS[NGE\3979C_6W?L_K0MZ*XW8    #GFZAOISW8^=%Q^/<7+)^YHY(>9>
MLWYIF/M*O"TV9*# .E7"/^2\0^XEO_HT92+OISRR]5Z?_36_B4^"&4'S98
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M7:";(;[!N+?:56V#'YE6PQR)HE77QKPD3RL@7CKWOT3ZER!Q,K)CEU
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MU)VI_P!K_,^HK )YJ0 L_P#9O_IE_-W\9D#K?J<_B;;[+/[K^7]=9\03;8
M  .>;J&^G/=CYT7'X]Q<LG[FCDAYEZS?FF8^TJ\+39DH, Z?2B/6P      #
MGZZG?I]W3^[<GQ;"X9#W%'(\U];?S;,?'\C0YEJZ = W3%] .UGW%C^,>4_/
M^_KY7I3JE^4Y?XGCEO<Q%B      K!]I!^AK\XOQ83NB>OS>-J3M3_M?YGU%
M8!/-2 %E?LY/ZZW6_F5I^,JB#UK91S^)M7LN]YF.2CPU+4B ;A
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MGN#4:J=O+ST2N3SF'-&&9BKAHGO3'E66C-35H5=G'T<Q3/-517XZ%_)4'I$
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M57C1A/1IFK":9W\(G#&*MSD0<_P1WH_RAS7[P7'^0)7[U9^'3W8:^_Q_4O\
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MTJ\+39DH, Z5<(_Y+Q#[B6_^C1E(N^G/++U7I_\ 36_B4^"&4'S98
M!1]UQ4C*;J$R"9FG-<+9:ZB71$3TFTS8>*]_"-.):M*G&Q'++S]V@T13J]<\
M--,][#Q(ADBI0!E='<G18/D5G1WHUU]LU8K>/%:2FND:+VZ</6%[CYS3Y\3Q
M3XF91=PRM='#71/S8KCZSI2*0]5                          ^/>L>L.
M24OJ.0V6AO='Q5M-701U#&JJ:*K4D:NB^=.(&L)>GG9B:1TK\#HD<]=51DM2
MQOO-9*B)[R!SBS/&]NL$Q!Z38UB5KM%2U%:E;!3L]8T7M19W(LBIYN8.&:
M             4Q=?UL6BWNM]:C%1EXQ>AJ/$XZ*^.HJH%35>&J)&FJ)Y4\I
M9M(JQLS'!,^)HGM)M=#4Z:OA6Z9[]4>)!\E6OP"6?1)<6T/4/BE.]6I\K45T
MHT5WE2BEG31=4T5?!T_:([5*<;$\6'A7/J!=Z&KVX^%%4?NS/B7E%5>@P
M        0XZZ_H"N'W;MOQCB2TGW_-*C=H?Y35\>E226EH( L#]G?])V;_-=
M?Z;3D/K/NZ>7Q-E=F/\ 6W?L_K0MZ*XW8  *$NKJ:6HZB]S'RNYWMJJ*-%T1
M/1CM]*QB<-.QK40MVG1AEZ?TWY><NNM4U:Q?QX:>]32C>9JK
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M=S"9WU>A,M9@%E?LY/ZZW6_F5I^,JB#UK91S^)M7LN]YF.2CPU+4B ;A
M!SS=0WTY[L?.BX_'N+ED_<T<D/,O6;\TS'VE7A:;,E!@'2KA'_)>(?<2W_T:
M,I%WTYY9>J]/_IK?Q*?!#*#YLL        I:Z^7L?OI UCVN=%C-O;(U%15:
M[Q:EVB^1=%12SZ1[GGEH?M'F)U2/LZ?#4A.2B@@ #I]*(];
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M 3O]GI]-&3_,JM_"-M(G6?<Q\;Q2V)V9_F5S[*?I4+CBM-Y
M   ",'69_ILW(_L?\,4)GZ9_44\_@E4>O7Y-?^1].E1"6QYW )W^ST^FC)_F
M56_A&VD3K/N8^-XI;$[,_P RN?93]*A<<5IO(      !6#[2#]#7YQ?BPG=$
M]?F\;4G:G_:_S/J*P">:D +/_9O_ *9?S=_&9 ZWZG/XFV^RS^Z_E_76?$$V
MV    #GFZAOISW8^=%Q^/<7+)^YHY(>9>LWYIF/M*O"TV9*# .GTHCUL
M   Y^NIWZ?=T_NW)\6PN&0]Q1R/-?6W\VS'Q_(T.9:N@'0-TQ?0#M9]Q8_C'
ME/S_ +^OE>E.J7Y3E_B>.6]S$6(     "L'VD'Z&OSB_%A.Z)Z_-XVI.U/\
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M:5>%ILR4& =*N$?\EXA]Q+?_ $:,I%WTYY9>J]/_ *:W\2GP0R@^;+
M  *.NN"N;5]0V2P-Y=;9;K73/T[=74D<_'SZ2H6K2HPL1RSX7GWM N=+5[D<
M%-,?NQ/C1')%2P#ZL-"DECN-RY$5:2NHZ9)-5U3UB*J?IIV+KX/;YCK,^=$?
MIO/M3;QM55\$Q'=BKR.F@HSU@
M         ,#W0Q!F?;=YIAKFM=)D-HJJ2C5VB(VI=&JT[^.B>A*C7>\?:Q<]
MG<IJX)1VKY&,[D[MCX=,Q'+AN=R<'.'-#+3S2T\\;H9X'NCFA>FCFO:NCFJB
M]BHJ:%UB<7ENJF:9PG;#Q!P 7C]%.;-R[8JQV^6?Q;CA5346.L:J^DD<;O&I
MET7ZE(96L1?L5\A5=4M="_,[T[KT%U"U#[UI=%,SYUN9HGPT_NS$<R6Q'+H
M         $..NOZ KA]V[;\8XDM)]_S2HW:'^4U?'I4DEI:" + _9W_2=F_S
M77^FTY#ZS[NGE\3979C_ %MW[/ZT+>BN-V  "FGV@%F?0;SVBZHU? OV,TDB
MR+V>+3SU$+VIQ7L8UB^^6;1ZL;,QP2T7VDV.AJ5->]5;CNQ,QX,$&"5:] )M
M] E=ZIOG5P<_+\IXO<*;337FY9Z6?37N_@M=2+U>,;//'C7[LWN='5)CAMU1
MWZ9\2Z(K#?                 C!UF?Z;-R/['_  Q0F?IG]13S^"51Z]?D
MU_Y'TZ5$);'G< G?[/3Z:,G^95;^$;:1.L^YCXWBEL3LS_,KGV4_2H7'%:;R
M       5@^T@_0U^<7XL)W1/7YO&U)VI_P!K_,^HK )YJ0 L_P#9O_IE_-W\
M9D#K?J<_B;;[+/[K^7]=9\03;8    .>;J&^G/=CYT7'X]Q<LG[FCDAYEZS?
MFF8^TJ\+39DH, Z?2B/6P      #GZZG?I]W3^[<GQ;"X9#W%'(\U];?S;,?
M'\C0YEJZ = W3%] .UGW%C^,>4_/^_KY7I3JE^4Y?XGCEO<Q%B      K!]I
M!^AK\XOQ83NB>OS>-J3M3_M?YGU%8!/-2 %E?LY/ZZW6_F5I^,JB#UK91S^)
MM7LN]YF.2CPU+4B ;A  &%[BYG0[>8-E6;7'1U-C=NFK&PJNGC3-;I#"B^66
M16L3SJ?6S:F[7%,;\L#5,_3D<K<S%6RBF9Y9WHYYPASFW^^7/)KW=\BO52ZL
MNU\K)JZY53NU\T[U>]=.Y-5X)W%THHBBF*8V0\O9G,5YB[5=N3C55,S,\<[K
MY!V?$ O0Z1-FZ;:W;"W72NI$9F.<00W2_3R-TEAAD;STM'Q35J1L=JY%^K<[
MR(534<S-ZY,1Z,;D>5Z%ZDZ%3IN1IKJC^+<B*JN&(]6GFC;QS*5I'KB
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M'BG]F?#":MV,-+N7>&];I[E%R9\,.B$ICTX
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MB/;_ .^PXL/&V/\ A,_XK[3#=]I[3FQ]GX-WOK@BMMW@
M                            !#+K:VFDW VN_*BTTJSY'MXZ2X1LC;S2
M36Z1$2MC31-?01K9?<8Y$XJ2>EYCV=SHSLJ\.\HG7_19SV1]M1&-=K=Y:?6C
MFW*N:5)Y:&A #Z%JNE?8[I;KU:JE]%<[3515ENK(UT?%/ ])(WM\[7-13BJF
M*HF)V2^EF]79KIN43A53,3$\$QNPZ$MD-U;9O%MU8\QH71QU\D:4N1VYB_\
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MB3,1RQN71/28JJUW#M12DW;<VZIIG;$O4V1SE&<L47Z/1KIB8Y][FV,E.C+
M              (P=9G^FS<C^Q_PQ0F?IG]13S^"51Z]?DU_Y'TZ5$);'G<
MG?[/3Z:,G^95;^$;:1.L^YCXWBEL3LS_ #*Y]E/TJ%QQ6F\@      %8/M(/
MT-?G%^+"=T3U^;QM2=J?]K_,^HK )YJ0 L_]F_\ IE_-W\9D#K?J<_B;;[+/
M[K^7]=9\03;8    .>;J&^G/=CYT7'X]Q<LG[FCDAYEZS?FF8^TJ\+39DH,
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MVV<S(Q$EDR5&/?WJUE' K4]Y7+^R5S6?>4\GC;K[,8C[E=G?]I]6%@Y#ME@
M   YYNH;Z<]V/G1<?CW%RR?N:.2'F7K-^:9C[2KPM-F2@P#I5PC_ )+Q#[B6
M_P#HT92+OISRR]5Z?_36_B4^"&4'S98      "*?69GC,)V,R*DAF2.Z9L]F
M/T#->*QU.KJM=.U4]78]ONN0D-,L^TO1.]&[Y.^IW7K48R>EUTQ/G7/,CG]+
M]W&.=1<6MYZ /;H*&KNE?16R@A=4UUQGCI:.G;\*269R,8U/.KE1#B9B(QEW
MMVZKE<44QC,S$1RRZ'_\+[=_@U_A#SM]1_)7\G/6M.'-ZIX'K&FGPN?[9V=I
M3?;S[;VG'B]-_A%'X=]RWO9]#'Y.&/=W6TS'3
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MT<C%T<Q[5X.:Y$5"J7;55NKHU1A+T-D<]9SMF+UBJ*J)WX\$\$\3)SYLL
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MC&VK<YM]>.H&E3G-1B[5'F6O.GXWJ1W?.^2NW*LW\
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M#GVJ?2R-(@%@?L[_ *3LW^:Z_P!-IR'UGW=/+XFRNS'^MN_9_6A;T5QNP
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M;8    .>;J&^G/=CYT7'X]Q<LG[FCDAYEZS?FF8^TJ\+39DH, Z?2B/6P
M   #GZZG?I]W3^[<GQ;"X9#W%'(\U];?S;,?'\C0YEJZ = W3%] .UGW%C^,
M>4_/^_KY7I3JE^4Y?XGCEO<Q%B      K!]I!^AK\XOQ83NB>OS>-J3M3_M?
MYGU%8!/-2 %E?LY/ZZW6_F5I^,JB#UK91S^)M7LN]YF.2CPU+4B ;A  $..N
M;#9,GV.J[M2PK+5X3<Z6[^BFKEIW<U+.B>9$G1Z^9A):5=Z%[#AC!1NT+(SF
M-,FN(W;=45<WHSX<>9226EH( \U/434L\%532N@J*:1LM/,Q=',>Q4<UR+W*
MBIJ<3&+FFJ:9B8W)AT1;*[FV_=S;?',THWQI5UD"4]^HV+_\-<8$1M3$J=J)
MS>DW7M8YJ]Y3<U8FS<FF>;D>G=!U:C5,G1?IVS&%4<%4>E'CCBF);5,=,
M  K:ZNNJ^EMU)=-JMLKFE1=ZE'TF89/3.U921N31])2RM7C*[56R/3@Q-6IZ
M>O)-Z=I\S,7+D;F]'C:KZZ]<J;=-63RE6-4[E=4;T?!IGAX9WMFW95.6!IT
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M<AZ.ZHZ'^%9&FBJ/XE?G5\L[*?DQN<N,[Z1IA+0
M                            CYU!=/N-[Z8WZM4^':LPM4;UQG)D9JZ)
MR\?5ZC3B^!Z]J=K5])O'5'9F3SE67JX8G;"M=9>K5G6;.$^;=I]&K@XIX:9[
MVV..C;.\"RO;;)*W%,QM,MHN]$NO(_C'-$JKR302)Z,D;M.#FKY47145$M=J
M]3=IZ5,XP\^:CIM_3[TV;]/1JCOQPQ._'&PX^C!  &W]O]^]W-L4C@P_-J^B
MML?99*E6UE#IJFJ-IJA)&,UTT56(UWG,:]E+5WTJ=WAWTWIO6/4-.W+%V8I^
M#/G4_-JQB.;"4O\ $_:)912,CAS;;^W7I4]%]=:*J2@?^Z6*9M2UR^9'-3W.
MPCKFC4SZ-4QR[OD7;)=I]^F,,Q9IJXZ9FGO3TO##>EG]H'LY6L8EUL>3V2=>
M7Q-:6FJ(4U[='QU/.J)^X0Q*M'O1LF)6*QVE:=7Z=%RF>2)CO58]YF,/7#T]
M2Q>(_(KE3/X_:)+75*[AYV,>WC[I\ITJ_P $=UG4]H&D3&,UU1\F?(^)7=>V
MQ-)&CX&9)<W:*OA4UNC:[AIHGV^>)..OE.\:1?G@[K'N=HVETQN>TGDICQS#
M4N2>T7M;&R1XAMK553W)]JK+Q7,@1J^5T%.R;F_C4,BC19]:KN0A<UVH41N6
M+$SQU58=Z(GPHI;@=8.^.?1U%&[)&XE::A%:^V8]&M'JU>YU2KGU"ZIP5$D1
M%\A(6=-LV]W#&>/],%.U+KOJ>=B:>G[.F=ZCS?WMVKOHPO>^5[Y97NDDD<KI
M)'*JN<Y5U555>*JJF>J,S,SC+\  + _9W_2=F_S77^FTY#ZS[NGE\3979C_6
MW?L_K0MZ*XW8    "F_K$Z;)=O+S5;DX90JN"7ZHYKO0PM]&TULSN*(U.R"9
MR^@O8QR\G!%9K9=-SWM8Z%7I1WX\K1G7CJK.1N3FK$?P:IW8CU*I^K.]P3N<
M""1+->  "0&UG4UNYM(R"@L%_2Z8]!P;C%X:M51M37LB])LL*>:-[4\J*8>8
MR-J]NS&$\,+)H_6S4-+B*;=?2HCU:MVGFWXYIA-[$O:)XO41Q19QM_<[5,B(
MV6LLL\5;&YW>[PJA:9S$\W.]?=(NYHU4>A5$\NYY6P,EVGV*HPS%FJF>&F8J
M[T]'#NRW3;NM[IXK6QNJ<IK[0KT57,J[56N5G#71WJT4Z>;@JF+5I5^-['GA
M/6NO^D5[;DT\M-7U8E[E7UJ=.5.U'0YS/7JNNK(+3<T5-.S7QJ:-./NG$:7F
M)]7OQY7>OK[H].R[,\E%?CIAK+(_:#[56^.1F-XSD.253458UF9!04SEXZ)X
MCI)9$_BC[T:/=GTIB.^B<UVEY"W'\*W77/'A3'=QF?W43=Q.NG=[+XIZ'&6T
M>WMLF16N=;D6HKU:NNJ+5S)Z/#3THXV.\Y(6=)M4;M7G3WNXIFI]H>H9J)IM
M86J?V=VKYT^*(E#6MKJVY5=17W&LGN%=5O66KK:F1TLTKW=KGO>JN<J^55).
M(B(PA1KERJY5-54S,SMF=V9>J<NB?O0CO%5XUF<VU5R66HL&:O?46=&HY_JE
MSAC5SEY6HNC)XV<KE[G-8O!.92(U;+171[2-L>!LCL[URK+YF<G7C-%S=C]F
MN(\%41N\<1QK@"MMW   !&#K,_TV;D?V/^&*$S],_J*>?P2J/7K\FO\ R/IT
MJ(2V/.X!._V>GTT9/\RJW\(VTB=9]S'QO%+8G9G^97/LI^E0N.*TWD
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M9LXL;%FQ7,XY53TV,I+>]J+YG+<&JO["&/\ @UWAI[_D3$=ING8;MN[W*?\
MO81D_M%K)'#+'AFW-=65#M4@J[U5QTS&>1SH:9)U?[B2-]T^UO1:O6J[B/S?
M:?:B,+%B9GAJF([U../=A"G=+J8W=W;9-0Y#D/R;8)M>;&+.UU'1.1?J941S
MI)D\TKW(G=H2>7R-JSNTQN\,J%J_6O4-3B:;M>%'P:?-IY]^KY4RT$9BM@ "
MP_HEZ>)\BO%)O!E]"K<<L<RNPVBF;PK:Z-=/6M%[8Z=R>BOU4G[A46&U3.=&
M/9T[9V\4?K;-Z@]6)OW(SU^/,IGS(GUJOA<E.]PU<BVXKK=(
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MU)VI_P!K_,^HK )YJ0 L_P#9O_IE_-W\9D#K?J<_B;;[+/[K^7]=9\03;8
M  .>;J&^G/=CYT7'X]Q<LG[FCDAYEZS?FF8^TJ\+39DH, Z?2B/6P      #
MGZZG?I]W3^[<GQ;"X9#W%'(\U];?S;,?'\C0YEJZ = W3%] .UGW%C^,>4_/
M^_KY7I3JE^4Y?XGCEO<Q%B      K!]I!^AK\XOQ83NB>OS>-J3M3_M?YGU%
M8!/-2 %E?LY/ZZW6_F5I^,JB#UK91S^)M7LN]YF.2CPU+4B ;A   "'W5ETX
MIO)C\.28O#&S<3&H',H&.5&-N5(BJ]U&]RZ(CVJJNB<O#55:NB.YFR6G9WV%
M71J]&>]QJ1USZK?BUJ+MF/XU$;G[=/P>7X/'N3MQBD^X6^OM-=5VRZ44]MN5
M!*^"NH*J-T4T,L:\KV21O1'-<U4T5%0M$3%48QL:#NVJ[54T5Q,51.$Q.Y,3
MQP],Y=  !D5LR_+;*V-EFRB[VED6JQ,HJV>!&ZIRKRI&]NG#A[ATJMTU;8B6
M5:SV8L^[N54\E4QX)>*Z93DU\:YMZR*YWAKUYGMK:N:H15U1=5\1[O(@IMTT
M[(B'6]G+][WE=57+,SX7PCNQP#/=NMM,RW4R*GQG"[1)<Z^71U5.NK::EB5=
M%FJ9=%2-B>5>*]C45=$/C>OT6:>E5*1TO2LSJ5Z+5BG&=_@B.&J=Z/TA=KL/
MTX8?LGCTU,R.*_Y7>J;P,GR2:/\ AF.XNIH&.U\.%.].U^B*[N1M7S>=KS%7
M!$;(;]ZN]5LOI%F8]*Y5&%54[_[,<%/AW^*FW?;:^NVBW-R/$9X7LMC9W5F,
MU+^*3VV=SEIWH[O5J(L;OLVN++E+\7[<5;^_RM&=8M(JTO.UV)CS<<:9X:)V
M>2>.):?,E" $O>C:X;N2;GT5@VZO#Z&P3O;6YQ!5,6>W-H8U:U\DD*JU/%=P
M9&K%:_5=->7F(W4Z;7L\:XW=[AQ7;J+=U"<]%O*U843NUX[M/1X9CX6]&&$\
M>&*\ JST   /A91>X<:QK(LCJ7,;3X_;*NY3N?\ !1E)"^9RNT[M&\3O;IZ=
M44\,L?-YB,O9KNSLIIFKYL8N:.662>62:5ZR2S/5\KU[7.<NJJONJ7AY2F9F
M<9>,.'V,>LU3D=_L>/435=67VX4UNI&HFJK+52MB8B)[KD.M=44TS5.]#[Y:
MQ5?NT6J=M544QRS."YWJ4Z4K/N[;H\@Q%(+%N!9Z5E/32/U2GN=/ SEBIJEW
M:U[41$CEXZ)Z+M6Z*RL9'4)LSA5NTSWF]NM74VWJE'M;&%-ZF,(X*XC935Q\
M%7-.YAA31DV+Y#AM[KL<RFT5-CO=M?X=9;JIBL>U>YR=SFN3BUS55KDXHJH6
M:BY37'2IG&&BLWE+V4NS:O4S37&V)_3N3LG>?!.['       39Z9>DN\[I55
M!F6<TT]FVXB>V:G@?S15-Y1%U1D'8YD"Z>E+PU3A'QU<R+SVHQ9CHT;M7@7[
MJGU+N:E5%_,1--C;P3<Y."GAJ^;PQ<Q;[?0VF@HK7;*2*@MMM@CI:"A@8D<4
M,,349'&QC=$:UK41$1"LS,U3C.UO6U:IM4111$13$81$;(B-D/<.'<
M                                              /XYK7-5KD1S7)H
MYJ\45%[45 ;42MT^C/:'<9]3<K91/P'(I^9RW*RL8VEDD7ZJ:A72)W%=5\/P
MW.[W$CE]3NVMR?.CC\JEZQU%T_/S-=$>RKG?IV<].SN=&9X4 <^Z'-Z<1=-4
M8_24>?VJ/5S9[5*V*J1B?7TE0K'*[[&)TG_\DO9U6S7M\V>/RM;:EV?:EE<9
MM1%VG]F<)^;.'[O213OV,9)BU6M!DV/W''JU%5/5+E2RTLG#MT;*UJJ2%%RF
MN,:9B5.S.4O9:KHW:*J)X*HF/"^$=V.    #),>PW+LMG2FQ;%[MD<ZNY5CM
MM'-5*B^?PF.T]\Z5W:*/2F(Y65ELCF,U.%FW57/[,3/@2;POHAWTRI\4EUM5
M%A%O?HY:J\U+%E5O?RT]-XTB.\ST9[I@7=5LT;)QY%LR'4#5,SNUTQ;IX:IW
M>Y3C/=P30V[Z!]L<;=35V<W2NSZXQZ.?0KK06Y'<%_@H7+,_1?KI>54[6=Q&
M7M7N5[E$=&.[*^:9V<9++X59BJ;M7!Z-/<C=GYV'$FM8<>L.+VR"S8W9J*PV
MFF_@+=00,IX6KWJC(T1-5TXKVKWD77757.-4XRON7RUK+41;M4Q33&]$81WG
MV#J^X       !%/>/I"VOW7EJ[S2P.PK+ZC5S[[:XV^#/(OU552+RLD55757
M-5CU[W*2&6U*Y9W-L<$^53M<ZDY'4YFY$>SN3ZU.R?C4[)Y8PGC5Q[A=%V]V
M$/GGMEECSRSQJJQU]A<LL_+JO*CZ)Z-GYE1.*1M>B?7*35G4[-S;/1GC\K5N
MI]0]3R<S-%/M:>&C=GYOI=S'E1:N=INEEK);?>;;56FX0\)J&MA?!,SN]*.1
M&N3L[T)"FJ*HQB<50NV:[-71N4S3,;TQA/<E\\Y?,  >U1T-;<:B.DM]'/7U
M<JZ14M/&Z61R^1K&(JK^P<3,1NR[V[=5R>C3$S/!&ZD5@_21OMG#X'PX9-C5
MNFT5;ID+OD]C4731?!>BU#D5%U]&)3"NZC8M^MC/%N_J6?3^I>J9S#"U-%/#
M7YO>]+N4IX;7=!& XT^FNFXUUFSNZ1*C_DF)'4EK8[MT<U%6:;1?*]K5[',4
MB<QJ]=>Y1&$=]L72.SC*9?"O-53=JX/1H\M7=B.&$ZK7:K99+?2VFS6ZFM-K
MH6>%16ZCB9!!"Q./+''&C6M3CV(A$U535.,SC+8=FS19HBBW3%-,;(B,(CDB
M'OG#Z     C]U38Q?\RV'SK&\7M4]ZOMR^3/4;93(BRR^#=*2:3E151/18QS
ME\R&9D+E-%^FJJ<(W?!*M=;\I=S>E7K5FF:JYZ.$1MG"NF9[T*>_U8M_?\K+
MW_%Q_ORR??['PX:0_P 2U;_CU_ISGZL6_O\ E9>_XN/]^/O]CX<'^):M_P >
MO].=,+HFV=W.V]W5O]ZS7"[CCEKJL4JZ*GK:MK6L?4/KJ&1L::.7BK8W+[Q&
MZIF;=VU$4U1,X^*5WZ@Z'G<CGZ[F8M544S;F,9X>E3.'>E:&0+;H      "O
MSKJVPS_<?_"W\AL6K<E^1OESY4]3:UW@>L?)_A<_,Y/A^$_3W"8TF_1:Z?3G
M#'#QM:]H>DYO/_=_N]N:^CT\<-['H8=W"5?OZL6_O^5E[_BX_P!^3'W^Q\.&
MM?\ $M6_X]?Z<Y^K%O[_ )67O^+C_?C[_8^'!_B6K?\ 'K_3G6!="NV&?[<?
MXI?ESBU;C7RS\A_)?KC6M\?U?Y0\7DY7+\#Q6:^Z0^K7Z+O0Z$XX8^)LKL\T
MG-Y#[Q]XMS1TNAACOX=/'N8PL#(=LH    %)>]O3UO5D.[NY%\LNW-VN-HNV
M05U5;J^%C%CFADE<YCVJKTX*BEHRN<LTVJ8FJ,8B&@M?ZLZE?U"_<MV*IIJK
MJF)X8Q:N_5BW]_RLO?\ %Q_OS(^_V/APB/\ $M6_X]?Z<Y^K%O[_ )67O^+C
M_?C[_8^'!_B6K?\ 'K_3G= I3WI0      !2UU =/^\V3[S;AW^P;>7:Z6:Z
M79\]ON$#&+'+&K&(CFJKTX<"SY/.6:+-,35$3$-#]9>K6I9C4KURW9JJIJJQ
MB8WVG_U8M_?\K+W_ !<?[\R?O]CX<(/_ !+5O^/7^G.?JQ;^_P"5E[_BX_WX
M^_V/AP?XEJW_ !Z_TYUTG3_8KQC&S.WE@O\ ;Y;7>;7:607"WSHB212(]ZJU
MR(J\=%*QG*XKO53&[$RWQU:R]S+Z;9MW(Z-5-.$Q.\W"8R<      K\ZZML,
M_P!Q_P#"W\AL6K<E^1OESY4]3:UW@>L?)_A<_,Y/A^$_3W"8TF_1:Z?3G#'#
MQM:]H>DYO/\ W?[O;FOH]/'#>QZ&'=PE7[^K%O[_ )67O^+C_?DQ]_L?#AK7
M_$M6_P"/7^G.?JQ;^_Y67O\ BX_WX^_V/AP?XEJW_'K_ $YT\NAG:O</;FZ[
MBS9QB==C45UI+:RW/K&M:DSHI*A7HWE<OP4<FOND3JN8MW8IZ$XX8MB]GNCY
MO(7+\YBW-'2BG#'?PQQ6)D*V>    "-6^O2_@6]L3KE4(N,YK%'R4N64<:.=
M(C4T:RLAU:D[4X:+JCTTT1Z)P7.RF?KR^YMIX/(JG6'JCE=7CISYEW>KCZT>
MM'?XU3VYG2YO'M?)437/%YK]8H556Y)8VNK:7D33TI6L;XL*<4_A6-37L52P
MV,_9O;)PG@EIK5NJ&HZ=,S7;FJCX5'G1S[]//$(\JBHJHJ:*G!44S%9?P
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MEH+A3R4TS53@NL<K6N3]@E*:Z:HQIG&%"OY:[EZNA=IFFK@F)B>Y+Y!V?$
M;?V^V&W9W.D@7$L+KZFWSZ*E]JF>J6]&KVN2IGY&/T3CHQ7.\QC7LW:M>E5N
M\&^F],ZN9_49CV-J9IGUI\VGYT[D\V,K*ME>AG$,+EI;_N7509UD,*MD@LS&
M*EHIWI]<R1$=4JB]BO1K?+&O:0F:U6NYN4;D=_\ 4VKH/9[E\I,7,W,7*_@^
MI'_=SX1^RGDQC8VM8QJ,8Q$:QC4T1$3@B(B$0V+$8/T'(
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M(/R=S?;/D'U7P.;S^J^CJ8%SIX^?CCQK?DONO1_VW0Z/[&&'[K+3YLT
M
M  $?MSOU9?6)O\5/R#^5?2\7Y4]2^4OLM-/]Y]W3O,RQ]Y__ (^EAQ8X>16M
M6_!<9^^>QZ7[71Z?_<B)D/\ Y='/+S<OK7,G-\D_E%RZ:_4\OVC3RZ$C1^(?
M]>BI69_P_'C_ &?:_P#ZL4__ %W_ /WO_P#.'T_W_%WF'_\ 4/V__D;)P_\
M\O'Q8/D[Y)];]#F_*#Y9Y.;[/Y0^T>[IZ)\;GW_?QYL/$E,C_B.,='HX_M^T
M^OYOB3BP+_#+Y,=_AA^3/R/Z/B?DQZGZOWZ<WJ?HZ]O:1-[VF/\ $QQX\?&V
M#IOW+H?[3V?1_P#3Z.'[K/#Y)$   (U]2O\ @!^2;?\ ''U3EY7_ "!X.ORS
MS\-?4/"^V]NG-K]K[/$X&=D?;]+^%S\'.JO6O\)^[_\ ^AA^SA[SY&&[R^K\
M)!WHU_P5_P =K]\G?*OK?JCO\*OR@]7\?7E?ZYS^!Z'K'A? TX<GB=^A*ZG[
M;V$8X?M8=[F:^ZB_AOXI7T>ECA_"Z>&/[6S<Z6&SBZ6^MV*XW6
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* 6^']     #_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
